Digital/ News/ News physIQ licenses virtual trial tech to Janssen in multi-year deal Richard Staines biomarker, digital, Janssen, physIQ, virtual trials 0 Comment Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, Share X physIQ licenses virtual trial tech to Janssen in multi-year deal https://pharmaphorum.com/news/physiq-licenses-virtual-trial-tech-to-janssen-in-multi-year-deal/
biomarker, digital, Janssen, physIQ, virtual trials
0 Comment
